GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 282 filers reported holding GUARDANT HEALTH INC in Q1 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,212,181 | -50.1% | 74,635 | -39.7% | 0.00% | 0.0% |
Q2 2023 | $4,429,677 | -23.3% | 123,734 | -49.8% | 0.00% | -50.0% |
Q1 2023 | $5,772,147 | +10.2% | 246,252 | +27.9% | 0.00% | 0.0% |
Q4 2022 | $5,236,273 | -28.0% | 192,510 | +42.4% | 0.00% | -33.3% |
Q3 2022 | $7,276,000 | +139.4% | 135,165 | +79.4% | 0.00% | +200.0% |
Q2 2022 | $3,039,000 | -87.1% | 75,333 | -78.8% | 0.00% | -85.7% |
Q1 2022 | $23,563,000 | +0.4% | 355,725 | +51.7% | 0.01% | -12.5% |
Q4 2021 | $23,461,000 | -0.9% | 234,565 | +23.9% | 0.01% | 0.0% |
Q3 2021 | $23,666,000 | -44.9% | 189,310 | -45.3% | 0.01% | -52.9% |
Q2 2021 | $42,957,000 | +151.6% | 345,904 | +209.2% | 0.02% | +88.9% |
Q1 2021 | $17,076,000 | -20.7% | 111,861 | -33.0% | 0.01% | -10.0% |
Q4 2020 | $21,532,000 | -5.6% | 167,070 | -18.1% | 0.01% | -28.6% |
Q3 2020 | $22,807,000 | +36.3% | 204,042 | -1.0% | 0.01% | +16.7% |
Q2 2020 | $16,727,000 | +187.2% | 206,186 | +146.4% | 0.01% | +100.0% |
Q1 2020 | $5,824,000 | -15.7% | 83,676 | -5.3% | 0.01% | -40.0% |
Q4 2019 | $6,905,000 | +143.9% | 88,367 | +99.3% | 0.01% | +100.0% |
Q3 2019 | $2,831,000 | +164.3% | 44,348 | +257.3% | 0.01% | +150.0% |
Q2 2019 | $1,071,000 | – | 12,411 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |